These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18078628)

  • 1. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
    Guignard S; Dien G; Dougados M
    Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe hepatitis in a patient with adult-onset Still's disease treated with anakinra].
    Diallo A; Mekinian A; Boukari L; Mouas H; Zamy M; Nahon P; Gérin M; Fain O
    Rev Med Interne; 2013 Mar; 34(3):168-70. PubMed ID: 23182291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of anakinra in a case of refractory Still disease.
    Debiais S; Maillot F; Luca L; Buret J; Fautrel B; Renard JP
    J Clin Rheumatol; 2008 Dec; 14(6):357-8. PubMed ID: 19033875
    [No Abstract]   [Full Text] [Related]  

  • 4. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
    Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
    Mod Rheumatol; 2014 Nov; 24(6):1030-1. PubMed ID: 24313885
    [No Abstract]   [Full Text] [Related]  

  • 6. Anakinra in children and adults with Still's disease.
    Vastert SJ; Jamilloux Y; Quartier P; Ohlman S; Osterling Koskinen L; Kullenberg T; Franck-Larsson K; Fautrel B; de Benedetti F
    Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi9-vi22. PubMed ID: 31769856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset Still's disease with prominent polyserositis.
    Farooq Sheikh AS; Marks J; Hopkinson N
    Scott Med J; 2018 May; 63(2):63-66. PubMed ID: 29506437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute liver failure following anakinra treatment for adult-onset Still disease.
    Aly L; Iking-Konert C; Quaas A; Benten D
    J Rheumatol; 2013 Oct; 40(10):1775-7. PubMed ID: 24085761
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.
    Ruiz PJ; Masliah E; Doherty TA; Quach A; Firestein GS
    Ann Rheum Dis; 2007 Mar; 66(3):422-3. PubMed ID: 17179171
    [No Abstract]   [Full Text] [Related]  

  • 10. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
    Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
    Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
    Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
    Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
    Kalliolias GD; Liossis SN
    Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra).
    Fischer-Betz R; Specker C; Schneider M
    Clin Exp Rheumatol; 2011; 29(6):1021-3. PubMed ID: 22153586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease.
    Priori R; Ceccarelli F; Barone F; Iagnocco A; Valesini G
    Clin Exp Rheumatol; 2008; 26(5):933-7. PubMed ID: 19032833
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
    Albersmeyer MP; Hilge RG; Schulze-Koops H; Sitter T
    Rheumatology (Oxford); 2012 Sep; 51(9):1730-2. PubMed ID: 22513144
    [No Abstract]   [Full Text] [Related]  

  • 19. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
    Kalliolias GD; Georgiou PE; Antonopoulos IA; Andonopoulos AP; Liossis SN
    Ann Rheum Dis; 2007 Jun; 66(6):842-3. PubMed ID: 17513574
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
    Raffeiner B; Botsios C; Dinarello C; Ometto F; Punzi L; Ramonda R
    Joint Bone Spine; 2011 Jan; 78(1):100-1. PubMed ID: 21036649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.